Dextroamphetamine is the dextrorotatory enantiomer of amphetamine[A2505]. Dextroamphetamine was approved by the FDA in 2001 for the treatment of attention deficit hyperactivity disorder[L6010,Label].
Synonyms
(+)-α-methylphenylethylamine
(S)-α-methylbenzeneethanamine
(S)-(+)-amphetamine
Dexamfetaminum
(+)-α-methylphenethylamine
(S)-1-phenyl-2-aminopropane
(S)-amphetamine
(+)-amphetamine
(+)-(S)-amphetamine
Dexanfetamina
(S)-1-phenyl-2-propylamine
Dexamphetamine
Dexamfetamine
d-amphetamine
(S)-(+)-β-phenylisopropylamine
Dextroamphetamine adipate
Desamfetamina
(αS)-α-methylbenzeneethanamine
Dextroamphetamine sulfate
Dextroamphetamine saccharate
Dextroamphetamine
Dexamfetamina
Brand Names
Dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison
T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS.
Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682
